Disclosing DNA data
Ethicists ask, should participants of autism genomic studies have access to their own DNA?
From funding decisions to scientific fraud, a wide range of societal factors shape autism research.
Ethicists ask, should participants of autism genomic studies have access to their own DNA?
This summer will mark ten years since scientists sequenced the human genome. What have we gained from knowing those 3 billion base pairs?
Scientists have created machines to detect distinctive speech patterns in children with autism that go unnoticed by the naked ear.
Moving a drug from the lab bench to the pharmacy’s shelves takes about 10 years. But for one controversial autism treatment, the process might be much quicker.
The proposed connection between premature birth and autism may be more complicated than it seems, according to a new report. Early birth may not cause classically defined autism but, rather, may predispose children to autism-like symptoms that are part of a larger syndrome, the researchers say.
Several genetic and animal studies in the past year have found intriguing ties between autism and DISC1, one of the oldest candidate genes for psychiatric disorders.
Individuals who carry a large and rare deletion on chromosome 16 that is associated with autism are likely to have developmental delays, be obese or both, according to two studies published last week in Nature.
There’s good news for autism research tucked into President Obama’s 2011 budget proposal: $222 million of it, to be exact.
Guoping Feng’s perseverance has proven a boon to the hundreds of neuroscientists who rely on his most celebrated scientific achievement: two dozen mouse strains engineered to have brightly colored brain cells. By creating the first robust mouse model of obsessive-compulsive disorder, Feng has also found a way to study repetitive behaviors, one of the three core characteristics of autism.